BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18418594)

  • 21. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
    Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
    World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of
    Wang W; Ni X; Tang T; Wang J; Li Y; Song X
    Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is There a Role for [
    Cohen D; Perry C; Hazut-Krauthammer S; Kesler M; Herishanu Y; Luttwak E; Even-Sapir E; Avivi I
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35159016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.
    Hoffmann M; Kletter K; Diemling M; Becherer A; Pfeffel F; Petkov V; Chott A; Raderer M
    Ann Oncol; 1999 Oct; 10(10):1185-9. PubMed ID: 10586335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation.
    Albano D; Bosio G; Giubbini R; Bertagna F
    Leuk Lymphoma; 2017 Oct; 58(10):2328-2334. PubMed ID: 28270020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
    Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
    Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients.
    Weiler-Sagie M; Bushelev O; Epelbaum R; Dann EJ; Haim N; Avivi I; Ben-Barak A; Ben-Arie Y; Bar-Shalom R; Israel O
    J Nucl Med; 2010 Jan; 51(1):25-30. PubMed ID: 20009002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
    Mayerhoefer ME; Giraudo C; Senn D; Hartenbach M; Weber M; Rausch I; Kiesewetter B; Herold CJ; Hacker M; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M
    Clin Nucl Med; 2016 Feb; 41(2):101-5. PubMed ID: 26402137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG PET/CT in splenic marginal zone lymphoma.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [18F] FDG PET in gastric non-Hodgkin's lymphoma.
    Rodriguez M; Ahlström H; Sundín A; Rehn S; Sundström C; Hagberg H; Glimelius B
    Acta Oncol; 1997; 36(6):577-84. PubMed ID: 9408147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis.
    Treglia G; Zucca E; Sadeghi R; Cavalli F; Giovanella L; Ceriani L
    Hematol Oncol; 2015 Sep; 33(3):113-24. PubMed ID: 25047160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
    J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.
    Zhang WD; Guan YB; Li CX; Huang XB; Zhang FJ
    J Comput Assist Tomogr; 2011; 35(5):608-13. PubMed ID: 21926857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT.
    Weiler-Sagie M; Kagna O; Dann EJ; Ben-Barak A; Israel O
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1133-40. PubMed ID: 24570095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.
    Hirose Y; Kaida H; Ishibashi M; Uozumi J; Arikawa S; Kurata S; Hayabuchi N; Nakahara K; Ohshima K
    Clin Nucl Med; 2012 Feb; 37(2):152-7. PubMed ID: 22228338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
    Schaefer NG; Strobel K; Taverna C; Hany TF
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):60-7. PubMed ID: 17021808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.